IMARC Group, a leading market research company, has recently released a report titled “Angioplasty Balloons Market Report by Product Type (Normal Balloons, Cutting Balloons, Drug Eluting Balloons, Scoring Balloons), Application (Coronary Angioplasty, Peripheral Angioplasty), Material (Nylon, Polyurethane, Silicone Urethane Co-Polymers, and Others), End-User (Hospitals, Ambulatory Surgery Centers, and Others), and Region 2024-2032”. The study provides a detailed analysis of the industry, including the global angioplasty balloons market share, trends, size, and industry trends forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

The global angioplasty balloons market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 2.8% during 2024-2032.

Global Angioplasty Balloons Market Trends:

The global angioplasty balloons market is experiencing significant growth driven by various factors, such as the increasing prevalence of cardiovascular diseases, which has become a leading cause of death worldwide, is a primary driver, as these conditions often necessitate angioplasty procedures.

Additionally, advancements in medical technology have led to the development of innovative angioplasty balloons, including drug-coated and scoring balloons, which offer improved treatment outcomes. The rising adoption of minimally invasive procedures, preferred by patients and healthcare providers alike for their shorter recovery times and reduced risks, further fuels market growth.

Moreover, the aging global population, particularly in developed countries, contributes to the demand for angioplasty, as older adults are more susceptible to cardiovascular conditions.

Factors Affecting the Growth of the Angioplasty Balloons Industry:

Increasing Prevalence of Cardiovascular Diseases

The global rise in cardiovascular diseases (CVDs) has become a critical driver for the angioplasty balloons market. CVDs, including conditions such as coronary artery disease, heart attacks, and strokes, are leading causes of mortality worldwide. Sedentary lifestyles, unhealthy diets, and increased stress levels contribute to the growing incidence of these diseases. As more individuals are diagnosed with CVDs, the demand for effective and minimally invasive treatments, like angioplasty, is rising. Angioplasty balloons are a vital component of this procedure, as they are used to widen narrowed or blocked blood vessels in the heart. The increasing number of patients requiring angioplasty to restore normal blood flow and reduce the risk of heart attacks is directly boosting the demand for angioplasty balloons. 

Advancements in Medical Technology

The ongoing advancements in medical technology are playing a pivotal role in driving the growth of the angioplasty balloons market. Innovations in balloon designs and materials have led to the development of more effective and safer angioplasty balloons. For example, drug-coated balloons, which release medication to prevent the re-narrowing of blood vessels, have gained popularity due to their enhanced efficacy. These advancements have significantly improved patient outcomes by reducing the risk of restenosis, which is a common complication after angioplasty procedures.

Additionally, scoring balloons, designed with small blades or wires, offer better precision in opening severely narrowed arteries, making them particularly useful in complex cases. The introduction of these advanced balloons has expanded the range of patients who can benefit from angioplasty, further driving market demand. 

Rising Adoption of Minimally Invasive Procedures

The growing preference for minimally invasive procedures is a significant driver for the angioplasty balloons market. Minimally invasive techniques, such as angioplasty, offer numerous advantages over traditional open-heart surgeries, including reduced recovery times, lower risk of complications, and shorter hospital stays. Patients and healthcare providers increasingly favor these procedures due to their less invasive nature, which leads to quicker recovery and less post-operative pain.

The rising adoption of these procedures is also driven by the growing awareness of the benefits they offer, along with advancements in imaging technologies that allow for precise and safe interventions. As the population ages and the incidence of cardiovascular diseases rises, the demand for minimally invasive treatments like angioplasty is expected to grow.

Additionally, healthcare providers are increasingly equipped with advanced technologies that facilitate these procedures, further promoting their adoption.

Angioplasty Balloons Market Report Segmentation:

By Product Type:

·         Normal Balloons

·         Cutting Balloons

·         Drug Eluting Balloons

·         Scoring Balloons

Normal balloons represented the largest segment by product type due to their widespread use in routine angioplasty procedures and cost-effectiveness.

By Application:

·         Coronary Angioplasty

·         Peripheral Angioplasty

Coronary angioplasty represented the largest segment by application because of the high prevalence of coronary artery diseases globally.

By Material:

·         Nylon

·         Polyurethane

·         Silicone Urethane Co-Polymers

·         Others

By the material, the market is segmented into nylon, polyurethane, silicone urethane co-polymers, and others.

By End User:

·         Hospitals

·         Ambulatory Surgery Centers

·         Others

Ambulatory surgery centers represented the largest segment by end user due to the increasing preference for outpatient procedures that offer quicker recovery times.

Regional Insights:

·         North America

·         Asia-Pacific

·         Europe

·         Latin America

·         Middle East and Africa

North America was the largest market by region, driven by the high incidence of cardiovascular diseases and advanced healthcare infrastructure.

Competitive Landscape with Key Players:

The competitive landscape of the angioplasty balloons market size has been studied in the report with the detailed profiles of the key players operating in the market.

Some of These Key Players Include:

·         Abbott Laboratories

·         B. Braun Melsungen AG

·         BD (Becton, Dickinson, and Company)

·         Biotronik SE & Co. KG

·         Boston Scientific Corporation

·         Cardinal Health Inc.

·         Cook Medical LLC

·         Endocor GmbH & Co. KG

·         Johnson & Johnson

·         Medtronic Inc.

·         Terumo Corporation

Ask Analyst for Customized Report:

https://www.imarcgroup.com/request?type=report&id=2270&flag=C

Key Highlights of the Report:

·         Market Performance (2018-2023)

·         Market Outlook (2024-2032)

·         Market Trends

·         Market Drivers and Success Factors

·         Impact of COVID-19

·         Value Chain Analysis

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St

Brooklyn, NY 11249, USA

Website: imarcgroup.com

Email: [email protected]

Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800